EUVIMEDOtkrijte EUVIMED
ValidierungsstudieOpen access · CC BY 4.0

Validity of one‐time phantomless patient‐specific quality assurance in proton therapy with regard to the reproducibility of beam delivery

Lukas Cornelius Wolter iD, Fabian Hennings, Jozef Bokor, Christian Richter iD, Kristin Stützer iD

Medical Physics · 2025

DOI: 10.1002/mp.17637 ↗

At a glance

Validierungsstudie in Medical Physics, 2025. Written by Lukas Cornelius Wolter and 4 co-authors. Institution: OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität D…. Major MEDLINE topics: Proton Therapy, Quality Assurance, Health Care, Phantoms, Imaging. Cited 4 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY 4.0).

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Background

Patient‐specific quality assurance (PSQA) is a crucial yet resource‐intensive task in proton therapy, requiring special equipment, expertise and additional beam time. Machine delivery log files contain information about energy, position and monitor units (MU) of all delivered spots, allowing a reconstruction of the applied dose. This raises the prospect of phantomless, log file‐based QA (LFQA) as an automated replacement of current phantom‐based solutions, provided that such an approach guarantees a comparable level of safety.

Purpose

To retrieve a reliable LFQA conclusion from a one‐time plan delivery before treatment initiation, deviations between planned and logged parameters must either be persistent over all following treatment fractions or, in case of random fluctuations, must not have a relevant impact on the reconstructed dose distribution. We therefore investigated the reproducibility of log file parameters over multiple patient treatment fractions and compared the reconstructed dose distributions.

Methods

Log file variability was examined at both spot parameter and integral dose levels. The log files of 14 patient treatment plans were analyzed retrospectively for a total of 339 delivered fractions. From the recorded x / y position and MU parameters per spot, the respective mean difference to the planned value (accuracy) and the standard deviation (reproducibility) were calculated for 108,610 planned spots. The dose distributions reconstructed from the log files of each fraction were evaluated against the planned fraction dose using 3D gamma index analysis. The dose‐based gamma pass rate was correlated with a new spot‐based log file pass rate . Beam timing information from the log files was used to quantify the total plan/field delivery time stability after excluding machine interlocks.

Results

The mean spot‐wise accuracy with respect to distance from planned positions and MUs was (0.6 ± 0.3) mm and (0.0001 ± 0.0023) MU, respectively. The mean reproducibility of the observed single spot deviations was (0.2 ± 0.1) mm and (0.0004 ± 0.0004) MU (mean ± standard deviation). These variations resulted in minimal changes in the reconstructed fraction dose with (2 mm/2%) > 99% for all studied fractions. Results for more sensitive criteria (1 mm/1%) were plan‐specific, but on average > 92.6% per plan and correlated with (1 mm) pass rates (0.51 ≤ r Pearson ≤ 0.99). Field delivery times were reproducible within ± 4 s (2σ) and no treatment interruptions were observed in 92.8% of cases.

Conclusions

The log file records of plan‐relevant spot parameters are well‐reproducible over multiple fractions and deviations have no dosimetrically relevant impact on the reconstructed fraction doses. Results of a one‐time pre‐treatment LFQA are considered as valid for the entire treatment course and there is no concern in this regard to replace state‐of‐the‐art phantom measurements in the current PSQA workflow.

Subjects

MeSH terms (MEDLINE)

Proton TherapyQuality Assurance, Health CarePhantoms, ImagingHumansReproducibility of ResultsRadiotherapy Planning, Computer-AssistedRadiotherapy DosageTime Factors

Author keywords

AutomationLog file‐based dose reconstructionPencil beam scanningProton therapyQuality assurance

Authors and institutions

  • OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.
  • Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiation Oncology, Dresden, Germany.
  • Ion Beam Applications Particle Therapy GmbH, c/o Universitätsklinikum Dresden, Dresden, Germany.
  • Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

ORCID profiles: Lukas Cornelius Wolter, Christian Richter, Kristin Stützer

Cite

APA

Wolter, L. C., Hennings, F., Bokor, J., Richter, C., & Stützer, K. (2025). Validity of one‐time phantomless patient‐specific quality assurance in proton therapy with regard to the reproducibility of beam delivery. Medical Physics. https://doi.org/10.1002/mp.17637

Vancouver

Wolter LC, Hennings F, Bokor J, Richter C, Stützer K. Validity of one‐time phantomless patient‐specific quality assurance in proton therapy with regard to the reproducibility of beam delivery. Medical Physics. 2025. doi:10.1002/mp.17637

BibTeX
@article{Wolter2025,
  author = {Wolter, Lukas Cornelius and Hennings, Fabian and Bokor, Jozef and Richter, Christian and Stützer, Kristin},
  title = {Validity of one‐time phantomless patient‐specific quality assurance in proton therapy with regard to the reproducibility of beam delivery},
  journal = {Medical Physics},
  year = {2025},
  doi = {10.1002/mp.17637}
}
Start for free →